# Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis

> **NCT03675022** · EARLY_PHASE1 · TERMINATED · sponsor: **Brigham and Women's Hospital** · enrollment: 9 (actual)

## Conditions studied

- Sleep Apnea
- Rhinosinusitis Chronic

## Interventions

- **DRUG:** Dupilumab

## Key facts

- **NCT ID:** NCT03675022
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-08-15
- **Primary completion:** 2022-07-01
- **Final completion:** 2022-07-01
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Inability to recruit during COVID
- **Last updated:** 2022-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03675022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03675022, "Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03675022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*